PubRank
Search
About
Ki Tae Yoon
Author PubWeight™ 12.66
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.
Dig Dis Sci
2008
1.35
2
Endoscopic papillary large balloon dilation in Billroth II gastrectomy patients with bile duct stones.
J Gastroenterol Hepatol
2012
1.15
3
Limited endoscopic sphincterotomy plus large balloon dilation for choledocholithiasis with periampullary diverticula.
World J Gastroenterol
2010
1.10
4
Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.
Antivir Ther
2011
1.02
5
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea.
Medicine (Baltimore)
2016
0.95
6
New diagnostic method for liver fibrosis and cirrhosis.
Intervirology
2008
0.91
7
A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.
Antivir Ther
2012
0.85
8
Clinical course of sorafenib treatment in patients with hepatocellular carcinoma.
Scand J Gastroenterol
2012
0.84
9
Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.
Am J Clin Oncol
2009
0.83
10
Endoscopic removal of a bile-duct stone using sphincterotomy and a large-balloon dilator in a patient with situs inversus totalis.
Gut Liver
2010
0.82
11
[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection].
Korean J Hepatol
2008
0.82
12
[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].
Korean J Hepatol
2010
0.80
13
Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
Pancreas
2011
0.77
14
Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea.
Medicine (Baltimore)
2016
0.77
15
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study.
Medicine (Baltimore)
2016
0.75
16
[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C].
Korean J Hepatol
2009
0.75
17
[Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report].
Korean J Gastroenterol
2009
0.75
18
[Natural history of HBeAg negative chronic hepatitis B virus infection: a cohort study].
Korean J Hepatol
2006
0.75
19
Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Eur J Gastroenterol Hepatol
2017
0.75
20
Sorafenib in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a report of four cases.
Korean J Gastroenterol
2015
0.75